Tornier (TRNX +4.3%) jumps after announcing preliminary Q4 sales of $69M (+12.7% Y/Y), beating Street estimates by $1.9M. The Dutch medical device maker's growth was driven by a 17.5% Y/Y increase in sales of prosthetics for extremities.
From other sites
at CNBC.com (Sep 24, 2014)
at CNBC.com (Jul 25, 2011)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs